---
title: "癌症病理基因大模型 DeepGEM 落地"
description: "记者 10 月 23 日从广州金域医学检验集团股份有限公司获悉，癌症病理基因大模型 DeepGEM 日前在该公司落地部署。依托这一大模型，该公司将与腾讯、广州医科大学附属第一医院共同开发病理基因多模态大模型，让准确、及时且普惠的基因突变预测新技术惠及更多癌症患者。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/262788924.md"
published_at: "2025-10-26T23:52:41.000Z"
---

# 癌症病理基因大模型 DeepGEM 落地

> 记者 10 月 23 日从广州金域医学检验集团股份有限公司获悉，癌症病理基因大模型 DeepGEM 日前在该公司落地部署。依托这一大模型，该公司将与腾讯、广州医科大学附属第一医院共同开发病理基因多模态大模型，让准确、及时且普惠的基因突变预测新技术惠及更多癌症患者。

记者 10 月 23 日从广州金域医学检验集团股份有限公司获悉，癌症病理基因大模型 DeepGEM 日前在该公司落地部署。依托这一大模型，该公司将与腾讯、广州医科大学附属第一医院共同开发病理基因多模态大模型，让准确、及时且普惠的基因突变预测新技术惠及更多癌症患者。

### Related Stocks

- [TCEHY.US - 腾讯控股(ADR)](https://longbridge.com/zh-CN/quote/TCEHY.US.md)
- [TCTZF.US - 腾讯控股(ADS)](https://longbridge.com/zh-CN/quote/TCTZF.US.md)
- [00700.HK - 腾讯控股](https://longbridge.com/zh-CN/quote/00700.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 18:01 ETBreakthrough Study Confirms HYD LLC's 30-Year Research on Deuterium Modulation in Cancer Gene Expression | A new study published in the International Journal of Molecular Sciences confirms HYD LLC's 30-year research on deuteriu | [Link](https://longbridge.com/zh-CN/news/275953157.md) |
| 11:03 ETNew Guidelines from NCCN Detail Fundamental Differences in Cancer in Children Compared to Adults | The National Comprehensive Cancer Network (NCCN) has released new Clinical Practice Guidelines for Pediatric Soft Tissue | [Link](https://longbridge.com/zh-CN/news/276145789.md) |
| 10:02 ETThe Center for Cancer and Blood Disorders Revolutionizes the Delivery of CAR-T Cancer Treatments for Texas Patients | The Center for Cancer and Blood Disorders has launched a program to deliver CAR-T therapy in community practices across  | [Link](https://longbridge.com/zh-CN/news/276139832.md) |
| Aprea Therapeutics Advanced Cancer Trial Shows Promising Results, Stock Soars | Aprea Therapeutics shares surged 16.62% to $0.70 following promising Phase 1 trial results for APR-1051, a WEE1 kinase i | [Link](https://longbridge.com/zh-CN/news/276264904.md) |
| Grail Stock Is Deeply Oversold on Cancer Test Failings. Is There Any Hope Left to Buy the Dip? | Grail Stock Is Deeply Oversold on Cancer Test Failings. Is There Any Hope Left to Buy the Dip? | [Link](https://longbridge.com/zh-CN/news/276486904.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。